Does UiPath’s (PATH) New CFO and 2027 Guidance Reframe Its Automation Profitability Story?

• UiPath, Inc. reported second-quarter 2026 revenue of US$410.26 million and net income of US$36.09 million, and also issued new guidance for fiscal 2027 while confirming leadership changes including the promotion of Hitesh Ramani to Chief Financial Officer.
• Beyond the stronger profitability, the combination of fresh earnings guidance and a refreshed finance and governance team signals a concerted effort to tighten execution across growth, oversight, and day-to-day operations.
• Next, we’ll examine how UiPath’s upgraded earnings guidance and new CFO appointment affect the existing investment narrative around automation and AI.

Find 47 companies with promising cash flow potential yet trading below their fair value.

UiPath Investment Narrative Recap

To own UiPath, you have to believe that demand for automation and AI orchestration will keep deepening across large enterprises, and that UiPath can turn that demand into steadily expanding, profitable recurring revenue. The latest quarter’s revenue and net income, together with new fiscal 2027 guidance and a reshaped finance and governance bench, matter most for the short term catalyst of consistent execution against ARR targets. They also touch the biggest risk right now: deal timing and macro uncertainty that can unsettle that ARR path.

Among the recent announcements, Banco Azteca’s large scale deployment of UiPath Maestro stands out as directly relevant. It shows how customers are using UiPath’s orchestration layer across thousands of processes and hundreds of automations, aligning with the catalyst that deeper adoption within existing accounts can support ARR growth. For investors, this type of reference customer can be as important as quarterly numbers when assessing whether the automation and agentic roadmap is really taking hold.

Yet while the headlines are encouraging, the risk that deal delays and cautious customer budgets could still unsettle UiPath’s ARR outlook is something investors should be aware of...

Read the full narrative on UiPath (it's free!)

UiPath's narrative projects $2.1 billion revenue and $287.5 million earnings by 2029. This requires 8.1% yearly revenue growth and a $39.9 million earnings decrease from $327.4 million today.

Uncover how UiPath's forecasts yield a $13.31 fair value, a 12% downside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were assuming UiPath could reach about US$2.2 billion in revenue and over US$530 million in earnings by 2029, which is far more bullish than consensus. They also lean heavily on Maestro driven AI orchestration as a key growth engine, so the latest guidance and leadership changes could either strengthen or weaken that view once they update their numbers.

Explore 10 other fair value estimates on UiPath - why the stock might be worth 12% less than the current price!

Form Your Own Verdict

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your UiPath research is our analysis highlighting 4 key rewards that could impact your investment decision.
• Our free UiPath research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate UiPath's overall financial health at a glance.

No Opportunity In UiPath?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• AI is about to change healthcare. These 37 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Uncover the next big thing with 22 elite penny stocks that balance risk and reward.
• The future of work is here. Discover the 36 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com